-
1
-
-
33745963843
-
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT)
-
DOI 10.1161/01.STR.0000227191.01792.e3, PII 0000767020060700000049
-
T. Yamaguchi, E. Mori, and K. Minematsu Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT) Stroke 37 2006 1810 1815 (Pubitemid 44297734)
-
(2006)
Stroke
, vol.37
, Issue.7
, pp. 1810-1815
-
-
Yamaguchi, T.1
Mori, E.2
Minematsu, K.3
Nakagawara, J.4
Hashi, K.5
Saito, I.6
Shinohara, Y.7
-
2
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
National Institute Of Neurological Disorders And Stroke Rt-Pa Stroke Study Group
-
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
3
-
-
0343990052
-
Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial
-
Ninds T-Pa Stroke Study Group
-
NINDS t-PA Stroke Study Group Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial Stroke 28 1997 2119 2125
-
(1997)
Stroke
, vol.28
, pp. 2119-2125
-
-
-
4
-
-
33846045948
-
Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications
-
DOI 10.1212/01.wnl.0000250341.38014.d2, PII 0000611420070102000012
-
A. Zangerle, S. Kiechl, and M. Spiegel Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications Neurology 68 2007 39 44 (Pubitemid 46058549)
-
(2007)
Neurology
, vol.68
, Issue.1
, pp. 39-44
-
-
Zangerle, A.1
Kiechl, S.2
Spiegel, M.3
Furtner, M.4
Knoflach, M.5
Werner, P.6
Mair, A.7
Wille, G.8
Schmidauer, C.9
Gautsch, K.10
Gotwald, T.11
Felber, S.12
Poewe, W.13
Willeit, J.14
-
5
-
-
0346340049
-
CLOTBUST Investigators. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator
-
C.A. Molina, A.V. Alexandrov, and A.M. Demchuk CLOTBUST Investigators. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 2004 151 157
-
(2004)
Stroke
, vol.35
, pp. 151-157
-
-
Molina, C.A.1
Alexandrov, A.V.2
Demchuk, A.M.3
-
6
-
-
0034161354
-
Intravenous tissue-type plasminogen activator for treatment of acute stroke: The standard treatment with alteplase to reverse stroke (STARS) study
-
G.W. Albers, V.E. Bates, and W.M. Clark Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study JAMA 283 2000 1145 1150 (Pubitemid 30126602)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.9
, pp. 1145-1150
-
-
Albers, G.W.1
Bates, V.E.2
Clark, W.M.3
Bell, R.4
Verro, P.5
Hamilton, S.A.6
-
7
-
-
39349090620
-
Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial
-
DOI 10.1161/STROKEAHA.107.492330, PII 0000767020080200000027
-
M. Yong, and M. Kaste Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial Stroke 39 2008 366 372 (Pubitemid 351619457)
-
(2008)
Stroke
, vol.39
, Issue.2
, pp. 366-372
-
-
Yong, M.1
Kaste, M.2
-
8
-
-
58149357100
-
SITS-MOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials
-
N. Wahlgren, N. Ahmed, and N. Eriksson SITS-MOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials Stroke 39 2008 3316 3322
-
(2008)
Stroke
, vol.39
, pp. 3316-3322
-
-
Wahlgren, N.1
Ahmed, N.2
Eriksson, N.3
-
9
-
-
54049111024
-
Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial
-
M. Yong, and M. Kaste Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial Stroke 39 2008 2749 2755
-
(2008)
Stroke
, vol.39
, pp. 2749-2755
-
-
Yong, M.1
Kaste, M.2
-
10
-
-
0343118114
-
T-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
-
The N.I.N.D.S.
-
N.I.N.D.S. The t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke Stroke 28 1997 2109 2118
-
(1997)
Stroke
, vol.28
, pp. 2109-2118
-
-
-
11
-
-
33645800351
-
Extent of early ischemic changes on computed tomography (CT) before thrombolysis: Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II
-
I. Dzialowski, M.D. Hill, and S.B. Coutts Extent of early ischemic changes on computed tomography (CT) before thrombolysis: Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II Stroke 37 2006 973 978
-
(2006)
Stroke
, vol.37
, pp. 973-978
-
-
Dzialowski, I.1
Hill, M.D.2
Coutts, S.B.3
-
12
-
-
0030950928
-
Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study
-
V. Larrue, R. von Kummer, and G. Zoppo Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study Stroke 28 1997 957 960 (Pubitemid 27209140)
-
(1997)
Stroke
, vol.28
, Issue.5
, pp. 957-960
-
-
Larrue, V.1
Von Kummer, R.2
Del Zoppo, G.3
Bluhmki, E.4
-
13
-
-
0035130531
-
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
-
V. Larrue, R. von Kummer, and A. Muller Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) Stroke 32 2001 438 441 (Pubitemid 32155231)
-
(2001)
Stroke
, vol.32
, Issue.2
, pp. 438-441
-
-
Larrue, V.1
Von Kummer, R.2
Muller, A.3
Bluhmki, E.4
-
14
-
-
0034643745
-
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
-
P.A. Barber, A.M. Demchuk, and J. Zhang Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy Lancet 355 2000 1670 1674 (Pubitemid 30248478)
-
(2000)
Lancet
, vol.355
, Issue.9216
, pp. 1670-1674
-
-
Barber, P.A.1
Demchuk, A.M.2
Zhang, J.3
Buchan, A.M.4
-
15
-
-
0035852125
-
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke
-
S.C. Patel, S.R. Levin, and B.C. Tilley National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke JAMA 286 2001 2830 2838 (Pubitemid 33126925)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.22
, pp. 2830-2838
-
-
Patel, S.C.1
Levine, S.R.2
Tilley, B.C.3
Grotta, J.C.4
Lu, M.5
Frankel, M.6
Haley Jr., E.C.7
Brott, T.G.8
Broderick, J.P.9
Horowitz, S.10
Lyden, P.D.11
Lewandowski, C.A.12
Marler, J.R.13
Welch, K.M.A.14
-
16
-
-
0026665797
-
Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke
-
R. von Kummer, and W. Hacke Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke Stroke 23 1992 646 652
-
(1992)
Stroke
, vol.23
, pp. 646-652
-
-
Von Kummer, R.1
Hacke, W.2
-
17
-
-
0026736173
-
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
-
E. Mori, Y. Yoneda, and M. Tabuchi Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke Neurology 42 1992 976 982
-
(1992)
Neurology
, vol.42
, pp. 976-982
-
-
Mori, E.1
Yoneda, Y.2
Tabuchi, M.3
-
18
-
-
33947538205
-
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke
-
DOI 10.1161/01.STR.0000257304.21967.ba, PII 0000767020070300000029
-
M. Saqqur, K. Uchino, and A.M. Demchuk CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 2007 948 954 (Pubitemid 46568457)
-
(2007)
Stroke
, vol.38
, Issue.3
, pp. 948-954
-
-
Saqqur, M.1
Uchino, K.2
Demchuk, A.M.3
Molina, C.A.4
Garami, Z.5
Calleja, S.6
Akhtar, N.7
Orouk, F.O.8
Salam, A.9
Shuaib, A.10
Alexandrov, A.V.11
-
19
-
-
70350527974
-
Arterial occlusion sites on MRA influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischemic stroke
-
T. Nakashima, K. Toyoda, and M. Koga Arterial occlusion sites on MRA influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischemic stroke Int J Stroke 4 2009 425 431
-
(2009)
Int J Stroke
, vol.4
, pp. 425-431
-
-
Nakashima, T.1
Toyoda, K.2
Koga, M.3
-
20
-
-
77649088870
-
Japan Alteplase Clinical Trial II (J-ACT II) Group. Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II)
-
E. Mori, K. Minematsu, and J. Nakagawara Japan Alteplase Clinical Trial II (J-ACT II) Group. Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II) Stroke 41 2010 461 465
-
(2010)
Stroke
, vol.41
, pp. 461-465
-
-
Mori, E.1
Minematsu, K.2
Nakagawara, J.3
|